# Executive Summary

## Context
Alzheimer’s disease is a progressive neurodegenerative disorder with substantial clinical and societal impact.  
Understanding how **clinical symptoms**, **functional abilities**, and **structural brain morphology** relate across diagnostic groups can support more informed clinical interpretation and research exploration.

This project applies a structured, fully reproducible data science workflow to analyze Alzheimer’s disease data using statistical methods and baseline predictive models within a professionally engineered pipeline.

---

## Objectives
The main objectives of this project are:

- To quantify differences in functional and symptom‑related measures across diagnostic groups.
- To explore relationships between clinical severity indices, daily functioning, and structural brain volume metrics.
- To evaluate whether brain morphology can predict individual clinical severity scores.
- To demonstrate a clean, modular, and reproducible data science workflow suitable for professional environments.

---

## Approach
The analysis follows an end‑to‑end pipeline:

- **Data preprocessing**  
  Standardized cleaning, numeric conversion, missing‑value handling, and separation of raw vs processed data.

- **Statistical analysis**  
  Group‑level comparisons using ANOVA and MANOVA, post‑hoc testing with Tukey HSD, and correlation analysis between structural brain metrics and clinical variables.

- **Predictive modeling**  
  Baseline regression models (Linear Regression and Random Forest) implemented in Python to assess whether brain volumes can predict clinical severity indices.

- **Evaluation**  
  Model performance assessed using **R²**, showing transparent and honest evaluation of predictive capacity.

- **Optional PySpark version**  
  A Spark‑based preprocessing notebook is included for scalability, but is not required for running the main analysis.

---

## Key Findings
- Several **functional activities** (e.g., bills, taxes, stove use, travel) show significant differences across diagnostic groups.
- Multiple **symptom severity indices** also differ significantly between groups.
- **Correlations** between brain volumes and clinical measures exist but are modest.
- **Predictive models show very low R²**, indicating that structural brain morphology alone does **not** predict individual symptom severity.
- Group‑level statistical significance does **not** translate into individual‑level predictability.

---

## Value and Relevance
This project demonstrates how clinical and structural brain data can be analyzed using rigorous statistical methods within a clean, modular, and reproducible engineering framework.

The results and structure are suitable for both technical audiences (data scientists, statisticians) and non‑technical stakeholders interested in data‑driven insights in healthcare.

---

## Next Steps
Potential future extensions include:

- Hyperparameter tuning and cross‑validation.
- Integration of additional biomarkers or longitudinal data.
- Model interpretability and explainability techniques.
- Exploration of multi‑modal predictive models combining clinical, functional, and biological data.
